摘要
目的 :观察氯沙坦对高血压患者心肌肥厚及心肌纤维化的影响。方法 :对 35例高血压伴左室肥厚患者用氯沙坦每日 5 0～ 10 0mg治疗 6mon ,用放疫法测定治疗前后血清中Ⅲ型前胶原 (PCⅢ )、层粘蛋白 (LN )、透明质酸 (HA)的含量 ,用超声心动图检测治疗前后左室质量指数 (LVMI )。结果 :氯沙坦治疗后 ,LVMI和血清PCⅢ、LN、HA均显著降低 (P<0 .0 5或P <0 .0 1) ;血压显著下降 (P <0 .0 1)。结论 :氯沙坦可显著降低血压 。
AIM: To investigate the effects of losartan on myocardial fibrosis and left ventricular hypertrophy in hypertensive patients. METHODS: 35 essential hypertensive patients with left ventricular hypertrophy were treated with losartan 50-100 mg for 6 mon. Before and after the treatment, serum procollagen typeⅢ (PCⅢ), laminin (LN), and hyaluronic acid (HA) were measured by radioimmunoassay; and left ventricular mass index (LVMI) was determined with ultrasonic cardiogram. RESULTS: After treatment with losartan: the serum levels of PCⅢ, LN, HA, and LVMI were all decreased (P<0.05 or P<0.01), and the blood pressure was also decreased significantly (P<0.01). CONCLUSION: Losartan can decrease blood pressure, and reverse the left ventricular hypertrophy and myocardial fibrosis in hypertensive patients.
出处
《中国临床药理学与治疗学》
CAS
CSCD
2002年第6期539-541,共3页
Chinese Journal of Clinical Pharmacology and Therapeutics
关键词
氯沙坦
高血压
左室肥厚
心肌纤维化
losartan
hypertension
left ventricular hypertrophy
myocardial fibrosis
